Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Genasys (GNSS) Cash & Equivalents (2016 - 2025)

Genasys (GNSS) has disclosed Cash & Equivalents for 16 consecutive years, with $8.0 million as the latest value for Q3 2025.

  • Quarterly Cash & Equivalents rose 61.15% to $8.0 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $8.0 million through Sep 2025, up 61.15% year-over-year, with the annual reading at $8.0 million for FY2025, 61.15% up from the prior year.
  • Cash & Equivalents hit $8.0 million in Q3 2025 for Genasys, up from $95000.0 in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $18.5 million in Q1 2021 to a low of $95000.0 in Q4 2024.
  • Historically, Cash & Equivalents has averaged $8.1 million across 5 years, with a median of $8.3 million in 2023.
  • Biggest five-year swings in Cash & Equivalents: soared 191.89% in 2024 and later plummeted 98.9% in 2025.
  • Year by year, Cash & Equivalents stood at $10.1 million in 2021, then fell by 25.38% to $7.6 million in 2022, then rose by 14.57% to $8.7 million in 2023, then tumbled by 98.9% to $95000.0 in 2024, then skyrocketed by 8288.42% to $8.0 million in 2025.
  • Business Quant data shows Cash & Equivalents for GNSS at $8.0 million in Q3 2025, $95000.0 in Q2 2025, and $5.7 million in Q1 2025.